YKL‐40 and phosphorylated protein levels of the ERK1/2 pathway in mice with laser induction were decreased after intravitreal injection with an anti‐YKL‐40 antibody, indicating that YKL‐40 may serve as a novel target for the diagnosis and treatment of wet AMD. Here, CHI3L1 is linked to wet macular degeneration.